Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities.
Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities.
复制标题
DOI:
10.3390/cancers14102539
复制
发表时间:
2022-05-21
期刊:
影响因子:
5.2
通讯作者:
Chua, Boon H.
中科院分区:
文献类型:
--
作者:
Farr, Katherina P.;Moses, Daniel;Haghighi, Koroush S.;Phillips, Phoebe A.;Hillenbrand, Claudia M.;Chua, Boon H.
关键词:
While survival rates for many cancers have improved dramatically over the last 20 years, patients with pancreatic cancer have persistently poor outcomes. The majority of patients with pancreatic cancer are not suitable for potentially curative surgery due to locally advanced or metastatic disease stage at diagnosis. Therefore, early detection would potentially improve survival of pancreatic cancer patients through earlier intervention. Here, we present clinical challenges in the early detection of pancreatic cancer, characterise high risk groups for pancreatic cancer and current screening programs in high-risk individuals. The aim of this scoping review is to investigate the role of both established and novel imaging modalities for early detection of pancreatic cancer. Furthermore, we investigate innovative imaging techniques for early detection of pancreatic cancer, but its widespread application requires further investigation and potentially a combination with other non-invasive biomarkers. Pancreatic cancer, one of the most lethal malignancies, is increasing in incidence. While survival rates for many cancers have improved dramatically over the last 20 years, people with pancreatic cancer have persistently poor outcomes. Potential cure for pancreatic cancer involves surgical resection and adjuvant therapy. However, approximately 85% of patients diagnosed with pancreatic cancer are not suitable for potentially curative therapy due to locally advanced or metastatic disease stage. Because of this stark survival contrast, any improvement in early detection would likely significantly improve survival of patients with pancreatic cancer through earlier intervention. This comprehensive scoping review describes the current evidence on groups at high risk for developing pancreatic cancer, including individuals with inherited predisposition, pancreatic cystic lesions, diabetes, and pancreatitis. We review the current roles of imaging modalities focusing on early detection of pancreatic cancer. Additionally, we propose the use of advanced imaging modalities to identify early, potentially curable pancreatic cancer in high-risk cohorts. We discuss innovative imaging techniques for early detection of pancreatic cancer, but its widespread application requires further investigation and potentially a combination with other non-invasive biomarkers.
登录
查看更多内容
影响因子:
24.5
作者:
European Study Group on Cystic Tumours of the Pancreas
通讯作者:
European Study Group on Cystic Tumours of the Pancreas
影响因子:
7.7
作者:
Andersen DK;Korc M;Petersen GM;Eibl G;Li D;Rickels MR;Chari ST;Abbruzzese JL
通讯作者:
Abbruzzese JL
DOI:
10.3390/diagnostics10121042
发表时间:
2020-12-03
期刊:
Diagnostics (Basel, Switzerland)
影响因子:
--
作者:
Arnone A;Laudicella R;Caobelli F;Guglielmo P;Spallino M;Abenavoli E;Martini AL;Filice R;Comis AD;Cuzzocrea M;Linguanti F;Evangelista L;Alongi P
通讯作者:
Alongi P
DOI:
10.1097/ppo.0000000000000109
发表时间:
2015-05
期刊:
Cancer journal (Sudbury, Mass.)
影响因子:
--
作者:
Dimastromatteo J;Houghton JL;Lewis JS;Kelly KA
通讯作者:
Kelly KA
影响因子:
51.1
作者:
Arnold, Melina;Rutherford, Mark J.;Bray, Freddie
通讯作者:
Bray, Freddie